Skip to main content
logo
SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
111,600
-3,500 (-3.04%)
Feb 5, 2026, 3:19 PM KST

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
New Pharmaceutical
1.14T
New Pharmaceutical Growth
221.86%
Important Adjustments
-594.66B
Important Adjustments
-594.66B

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Important Adjustments
-594.66B
Important Adjustments Growth
27.97%
United States
667.82B
United States Growth
31.23%
South Korea
474.43B
South Korea Growth
52.69%
Important Adjustments
-594.66B
Important Adjustments Growth
27.97%